Revenis Mary Ellen MD Washington, DC - 20010

Revenis Mary Ellen MD is categorized under Professional Organizations in Washington, DC and active since 2005.

Revenis Mary Ellen MD was established in 2005, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Professional Organizations business, which does work in the B2B market, and is classified as a Professional Organizations, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Mary Ellen Revenis at the company’s single location by writing to 111 Michigan Avenue Nw, Washington, District of Columbia DC 20010 or by phoning (202) 476-5464. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Revenis Mary Ellen MD
Contact Person: Mary Ellen Revenis
Address: 111 Michigan Avenue Nw, Washington, District of Columbia 20010
Phone Number: (202) 476-5464
Annual Revenue (USD): $500.000 to $999.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Professional Organizations
SIC Code: 8621
NAICS Code: 6211110
Share This Business:

Revenis Mary Ellen MD was started in 2005 to provide professional Professional Organizations under the SIC code 8621 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Mary Ellen Revenis for inquiries that concern Revenis Mary Ellen MD by calling the company number (202) 476-5464, as your correspondence is most welcome. Additionally, the physical location of the single location of Revenis Mary Ellen MD can be found at the coordinates 38.926328,-77.012535 as well as the street address 111 Michigan Avenue Nw in Washington, District of Columbia 20010.

For its online presence, you may visit Revenis Mary Ellen MD’s website at and engage with its social media outlets through on Twitter and on Facebook.